---
title: "Ascentage Pharma announces underwriters partially exercise option to purchase additional ADS"
date: "2025-02-07 17:00:49"
summary: "Ascentage Pharma (NASDAQ:AAPG) on Friday said the underwriters of its underwritten U.S. initial public offering have partially exercised their over-allotment option to purchase an additional 935,144 American depositary shares (ADSs) at $17.25 per ADS. Each ADS represents four ordinary shares of Ascentage Pharma. After giving effect to the partial exercise..."
categories:
  - "seekalpha"
lang:
  - "en"
translations:
  - "en"
tags:
  - "seekalpha"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

* Ascentage Pharma (NASDAQ:[AAPG](https://seekingalpha.com/symbol/AAPG "Ascentage Pharma Group International")) on Friday said the underwriters of its underwritten U.S. initial public offering have partially exercised their over-allotment option to purchase an additional 935,144 American depositary shares (ADSs) at $17.25 per ADS.
* Each ADS represents four ordinary shares of Ascentage Pharma. After giving effect to the partial exercise of the over-allotment option, the total number of ADSs sold by Ascentage Pharma in the offering will increase to 8.26 million ADSs.
* The company said the aggregate gross proceeds will be approximately $142.5 million.
* AAPG +2.39% premarket to $19.25.
* Source: [Press Release](https://seekingalpha.com/pr/19995520-ascentage-pharma-announces-partial-exercise-of-underwriters-option-to-purchase-additional)

[seekalpha](https://seekingalpha.com/news/4405134-ascentage-pharma-announces-underwriters-partially-exercise-option-to-purchase-additional-ads)
